Literature DB >> 8608521

Connatal localized neuroblastoma. The case to delay treatment.

R Kerbl1, C E Urban, H Lackner, G Höfler, I M Ambros, M Ratschek, P F Ambros.   

Abstract

BACKGROUND: Spontaneous regression is well documented for a subset of widespread neuroblastomas (Stage 4S) and for localized residual tumors after incomplete resection. Possible spontaneous regression of untreated localized neuroblastoma in infants is frequently discussed, but has very rarely been demonstrated clinically.
METHODS: We report four patients with localized neuroblastomas detected early; all were tumors of the adrenal gland. One patient was detected antenatally by ultrasound, the other three tumors were detected incidentally by sonography at age of birth, 1 week, and 7 weeks, respectively. In three patients treatment was delayed in order to await a possible spontaneous regression, and in one patient treatment was delayed due to an uncertain diagnosis.
RESULTS: Local tumor growth was observed in three patients, and the tumors were removed 7, 12, and 16 weeks, respectively, after the initial diagnosis of the neuroblastoma. All three patients are free of disease. The fourth patient developed liver metastases 4 weeks after the first suspicion of neuroblastoma. Progressive disease ended in death at the age of 17 months.
CONCLUSIONS: None of the four patients showed spontaneous tumor regression. Noninvasive examinations and invasive investigations (in two patients) were unable to predict the tumor's behavior. Based on present knowledge, a general "wait and see" strategy cannot be recommended for early and incidentally detected neuroblastoma patients.

Entities:  

Mesh:

Year:  1996        PMID: 8608521     DOI: 10.1002/(SICI)1097-0142(19960401)77:7<1395::AID-CNCR26>3.0.CO;2-W

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Heterochronous bilateral adrenal neuroblastoma: stage 4S in early infancy following resection of stage I lesion in the neonatal period.

Authors:  Kwang-Jong Lee; Tomonari Urabe; Masahiko Kouroki; Tadashi Anan; Fumio Endo; Yukihiro Inomata
Journal:  Pediatr Surg Int       Date:  2012-01       Impact factor: 1.827

2.  Neonatal neuroblastoma needs the aggressive treatment?

Authors:  So-Hyun Nam; Dae Yeon Kim; Seong Chul Kim; Jong-Jin Seo
Journal:  World J Surg       Date:  2012-09       Impact factor: 3.352

3.  Long-term follow-up of the "wait and see" approach to localized perinatal adrenal neuroblastoma.

Authors:  Denis Andrew Cozzi; Ermelinda Mele; Silvia Ceccanti; Fabio Natale; Anna Clerico; Amalia Schiavetti; Carlo Dominici
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

4.  Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis.

Authors:  M E Luttikhuis; J E Powell; S A Rees; T Genus; S Chughtai; P Ramani; J R Mann; C M McConville
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

5.  Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results.

Authors:  Vassilios Papadakis; Vanessa Segura; Massimo Conte; Dominique Plantaz; Andrea Di Cataldo; Gudrun Schleiermacher; Kate Wheeler; Jose D Bermúdez; Shifra Ash; Bénédicte Brichard; Ruth Ladenstein; Valérie Combaret; Sabine Sarnacki; Anna Maria Fagnani; Claudio Granata; Adela Cañete
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.